fib4c | 7246
FIB-4-Score
Keywords
FIB-4-index, FIB-4-Score, Fibrosis-4-Score
| Material |
|
|
| Note |
According to: Sterling RK, Lissen E, Clumeck N, et. al. Development of a simple noninvasive index to predict significant fibrosis patients with HIV/HCV co-infection. Hepatology 2006;43:1317-1325. |
|
| Stability | 2 days / 18-25°C | |
| Duration | 2 hours | |
| Frequency | continually, 7 days per week | |
| Price | CHF 0.00 | |
| Tariff | 0.00 TP |
Reference values
| Value | Sex |
|---|---|
| :metabolic dysfunc.-assoc. | f+m |
| :fatty liver disease: | f+m |
| high risk:> 2.67 | f+m |
| intermediate risk:1.3 - 2.67 | f+m |
| low risk:< 1.3 | f+m |
Team of consultants
|
Dr. sc. nat.
Corinne Ruppen
FAMH Specialist in laboratory medicine, main field clinical chemistry
|
FAMH Specialist in laboratory medicine, main field clinical chemistry | T |
|
|
PhD
Maurus Curti
FAMH Specialist in laboratory medicine
|
FAMH Specialist in laboratory medicine | T |
|
|
MD
Uta Deus
FMH General internal medicine, FAMH Specialist in laboratory medicine
|
FMH General internal medicine, FAMH Specialist in laboratory medicine | T |
|
|
Dr. rer. nat.
Kristina Vollmer
FAMH Specialist in laboratory medicine, main field clinical chemistry
|
FAMH Specialist in laboratory medicine, main field clinical chemistry | T |
|